HF
VBIO

HRT Financial’s Valion Bio VBIO Stock Holding History

HRT Financial’s Portfolio VBIO Stock Details VBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$37K Buy
+42,419
New +$43.4K ﹤0.01% 3498
2025
Q1 		– Sell
-3,450
Closed -$19K – 3381
2024
Q4 		$19K Buy
+3,450
New +$16.1K ﹤0.01% 2214
2023
Q3 		– Sell
-16
Closed -$2K – 3094
2023
Q2 		$2K Hold
16
– – ﹤0.01% 2289
2023
Q1 		$4K Buy
+16
New +$11.2K ﹤0.01% 2307

Other funds holding VBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

HRT Financial's VBIO Position: Q1 2026 in Review

HRT Financial opened a new position in Valion Bio (VBIO) in Q1 2026: 42,419 shares worth $37K. The stake represents ﹤0.01% of the portfolio and ranks #3498 among its holdings. This is a return to the name: HRT Financial previously reported a position in VBIO as recently as Q4 2024.

HRT Financial first reported a position in VBIO in Q1 2023 and has held it in 4 quarters since. 9 funds tracked by Wall St. Rank hold VBIO as of Q1 2026.

  • HRT Financial held 42,419 shares of Valion Bio worth $37K as of Q1 2026.
  • Valion Bio was a new HRT Financial position in Q1 2026.
  • Valion Bio made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3498 holding.
  • HRT Financial first reported a position in Valion Bio in Q1 2023 and has held it in 4 quarters since.
  • 9 funds tracked by Wall St. Rank held Valion Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.